{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:30:28Z","timestamp":1790688628296,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"am","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.therap.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T10:49:19Z","timestamp":1669632559000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?"],"prefix":"10.1016","volume":"78","author":[{"given":"Maylis","family":"Balon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Damase-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Andr\u00e9e","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Benevent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2022.11.005_bib0165","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bpobgyn.2013.08.001","article-title":"Alterations in physiology and anatomy during pregnancy","volume":"27","author":"Tan","year":"2013","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.therap.2022.11.005_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.therap.2022.11.005_bib0175","doi-asserted-by":"crossref","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.therap.2022.11.005_bib0180","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.therap.2022.11.005_bib0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2515\/therapie\/2014026","article-title":"Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring","volume":"69","author":"Panchaud","year":"2014","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.11.005_bib0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","article-title":"Uses of pharmacovigilance databases: An overview","volume":"75","author":"Bihan","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.11.005_bib0195","unstructured":"Council for International Organizations of Medical Sciences (CIOMS). International Working Group V. Current challenges in pharmacovigilance: pragmatic approaches. CIOMS, Geneva, Switzerland 2001. ISBN: 92 9036 074 7."},{"key":"10.1016\/j.therap.2022.11.005_bib0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2515\/therapie:2007067","article-title":"Effets ind\u00e9sirables des m\u00e9dicaments chez la femme enceinte","volume":"62","author":"Lacroix","year":"2007","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.11.005_bib0205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.therap.2022.11.005_bib0210","first-page":"557","article-title":"French pharmacovigilance database system: examples of utilisation","volume":"50","author":"Moore","year":"1995","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2022.11.005_bib0215","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clp.2007.11.015","article-title":"Medication errors in obstetrics","volume":"35","author":"Kfuri","year":"2008","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.therap.2022.11.005_bib0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1542\/peds.2012-0496","article-title":"Nonsteroidal antiinflammatory drugs in late pregnancy and persistent pulmonary hypertension of the newborn","volume":"131","author":"Van Marter","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.therap.2022.11.005_bib0225","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/BF00869093","article-title":"Renal failure in the neonate associated with in utero exposure to non-steroidal anti-inflammatory agents","volume":"8","author":"Kaplan","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.therap.2022.11.005_bib0230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccl.2012.04.002","article-title":"Arrhythmias in pregnancy","volume":"30","author":"McAnulty","year":"2012","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.therap.2022.11.005_bib0235","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1191\/0961203304lu1094oa","article-title":"Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity","volume":"13","author":"Cutolo","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.therap.2022.11.005_bib0240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0897.2010.00836.x","article-title":"The immune system in pregnancy: a unique complexity","volume":"63","author":"Mor","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.therap.2022.11.005_bib0245","unstructured":"Justiz Vaillant AA, Vashisht R, Zito PM. Immediate Hypersensitivity Reactions. StatPearls. 2022. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513315\/. [Accessed 25 November 2022]."},{"key":"10.1016\/j.therap.2022.11.005_bib0250","doi-asserted-by":"crossref","first-page":"116978","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal Anaphylaxis: Mortality Rate and Risk Factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.therap.2022.11.005_bib0255","first-page":"7904","article-title":"Anaphylaxis in terminal pregnancy: two case studies and review of the literature","volume":"28","author":"Sleth","year":"2009","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.therap.2022.11.005_bib0260","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/jpm11111060","article-title":"Severe anaphylaxis in pregnancy: a systematic review of clinical presentation to determine outcomes","volume":"11","author":"Simionescu","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.therap.2022.11.005_bib0265","doi-asserted-by":"crossref","first-page":"D84","DOI":"10.1016\/S0399-8320(04)94992-5","article-title":"The liver and pregnancy","volume":"28","author":"Chazouill\u00e8res","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.therap.2022.11.005_bib0270","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cld.2012.03.011","article-title":"Liver disease in pregnancy","volume":"16","author":"Mufti","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.therap.2022.11.005_bib0275","unstructured":"ANSM. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit - UTROGESTAN 100mg, capsule molle. Juillet 2012. http:\/\/agenceprd.ansm.sante.fr\/php\/ecodex\/rcp\/R0215159.htm. [Accessed 21 November 2022]."},{"key":"10.1016\/j.therap.2022.11.005_bib0280","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1016\/j.cld.2016.08.009","article-title":"Drug hepatotoxicity: newer agents","volume":"21","author":"Bunchorntavakul","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.therap.2022.11.005_bib0285","doi-asserted-by":"crossref","first-page":"113551","DOI":"10.1111\/j.1365-2036.2007.03307.x","article-title":"Review article: drug hepatotoxicity","volume":"25","author":"Chang","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.therap.2022.11.005_bib0290","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.therap.2020.07.002","article-title":"Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database","volume":"76","author":"Araujo","year":"2021","journal-title":"Therapies"},{"key":"10.1016\/j.therap.2022.11.005_bib0295","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000496966","article-title":"Safety of oral and intravenous iron","volume":"142","author":"DeLoughery","year":"2019","journal-title":"Acta Haematol"},{"key":"10.1016\/j.therap.2022.11.005_bib0300","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","volume":"6","author":"Flenady","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2022.11.005_bib0305","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.18773\/austprescr.2016.006","article-title":"Management of digoxin toxicity","volume":"39","author":"Pincus","year":"2016","journal-title":"Aust Prescr"},{"key":"10.1016\/j.therap.2022.11.005_bib0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.therap.2022.11.005_bib0315","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/1753495X18808118","article-title":"Maternal monitoring and safety considerations during antiarrhythmic treatment for fetal supraventricular tachycardia","volume":"12","author":"Malham\u00e9","year":"2019","journal-title":"Obstet Med"},{"key":"10.1016\/j.therap.2022.11.005_bib0320","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40262-019-00747-3","article-title":"Levothyrox\u00ae\u00a0new and old formulations: are they switchable for millions of patients?","volume":"58","author":"Concordet","year":"2019","journal-title":"Clin Pharmacokinet"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722002682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722002682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:44Z","timestamp":1758567344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595722002682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0040595722002682"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2022.11.005","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}